Does MOMELOTINIB Cause Off label use? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Off label use have been filed in association with MOMELOTINIB (Ojjaara). This represents 1.7% of all adverse event reports for MOMELOTINIB.
15
Reports of Off label use with MOMELOTINIB
1.7%
of all MOMELOTINIB reports
1
Deaths
4
Hospitalizations
How Dangerous Is Off label use From MOMELOTINIB?
Of the 15 reports, 1 (6.7%) resulted in death, 4 (26.7%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOMELOTINIB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does MOMELOTINIB Cause?
Thrombocytopenia (89)
Death (77)
Drug ineffective (75)
Anaemia (59)
Diarrhoea (51)
Myelofibrosis (51)
Condition aggravated (49)
Dizziness (41)
Pneumonia (41)
Fatigue (39)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which MOMELOTINIB Alternatives Have Lower Off label use Risk?
MOMELOTINIB vs MOMETASONE
MOMELOTINIB vs MOMETASONE FUROATE
MOMELOTINIB vs MOMETASONE FUROATE\OLOPATADINE
MOMELOTINIB vs MONOMETHYL
MOMELOTINIB vs MONTELUKAST